Severe dysautonomia in glycine receptor antibody-positive progressive encephalomyelitis with rigidity and myoclonus (PERM): A case report

Auton Neurosci. 2022 Jan:237:102910. doi: 10.1016/j.autneu.2021.102910. Epub 2021 Nov 16.

Abstract

Progressive encephalomyelitis with rigidity and myoclonus (PERM) is a severe form of stiff-person spectrum disorder. We report a 59-year-old man who presented with progressive encephalomyelitis causing diplopia, bulbar palsy, severe dysautonomia, followed by stiffness and myoclonic cluster. Laboratory tests showed mild pleocytosis, with markedly elevated plasma levels of norepinephrine, epinephrine, and arginine vasopressin. Glycine-receptor antibodies were identified in both serum and CSF. Despite a poor response to methylprednisolone, immunoglobulins, and plasma exchange, α-blocker stabilized dysautonomia. Dysautonomia is presumed to be due to antibody-mediated disinhibited sympathetic hyperactivity; however, this case suggests that concomitant use of α-blocker with immunotherapy may ameliorate dysautonomia.

Keywords: Dysautonomia; Glycine receptor antibody; Norepinephrine; Nucleus of the solitary tract; Progressive encephalomyelitis with rigidity and myoclonus; α-Blocker.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Encephalomyelitis* / complications
  • Encephalomyelitis* / drug therapy
  • Humans
  • Male
  • Middle Aged
  • Muscle Rigidity
  • Myoclonus* / drug therapy
  • Primary Dysautonomias*
  • Receptors, Glycine

Substances

  • Receptors, Glycine

Supplementary concepts

  • Progressive Encephalomyelitis with Rigidity